Iván Plaza-Menacho

1.7k total citations
27 papers, 1.3k citations indexed

About

Iván Plaza-Menacho is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Iván Plaza-Menacho has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Iván Plaza-Menacho's work include Cancer-related Molecular Pathways (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Iván Plaza-Menacho is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Iván Plaza-Menacho collaborates with scholars based in United Kingdom, Netherlands and Spain. Iván Plaza-Menacho's co-authors include Clare M. Isacke, Andrea Morandi, Robert M.W. Hofstra, Luca Mologni, Neil Q. McDonald, Bart J. L. Eggen, Grzegorz Burzynski, Carlo Gambacorti‐Passerini, Mitch Dowsett and David Robertson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Iván Plaza-Menacho

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iván Plaza-Menacho United Kingdom 20 598 490 248 241 240 27 1.3k
Brian C. Grabiner United States 11 1.1k 1.9× 441 0.9× 136 0.5× 164 0.7× 147 0.6× 11 1.8k
Aleata A. Triplett United States 22 728 1.2× 724 1.5× 218 0.9× 96 0.4× 75 0.3× 34 1.4k
Anna L. Stratford Canada 24 1.2k 2.1× 567 1.2× 122 0.5× 130 0.5× 503 2.1× 27 1.9k
Heidi L. Kenerson United States 23 801 1.3× 518 1.1× 133 0.5× 274 1.1× 47 0.2× 45 1.7k
Paolo Salerno Italy 16 667 1.1× 410 0.8× 123 0.5× 93 0.4× 379 1.6× 31 1.1k
Ayush Dagvadorj United States 19 672 1.1× 448 0.9× 160 0.6× 270 1.1× 107 0.4× 23 1.2k
Ploutarchos Anezinis Greece 15 542 0.9× 272 0.6× 198 0.8× 606 2.5× 144 0.6× 21 1.2k
Bin Chang China 21 717 1.2× 440 0.9× 78 0.3× 225 0.9× 66 0.3× 52 1.3k
Mika K. Derynck United States 15 648 1.1× 553 1.1× 331 1.3× 308 1.3× 121 0.5× 34 1.5k
Cuiqi Zhou United States 21 687 1.1× 279 0.6× 80 0.3× 75 0.3× 390 1.6× 35 1.3k

Countries citing papers authored by Iván Plaza-Menacho

Since Specialization
Citations

This map shows the geographic impact of Iván Plaza-Menacho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Plaza-Menacho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Plaza-Menacho more than expected).

Fields of papers citing papers by Iván Plaza-Menacho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván Plaza-Menacho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Plaza-Menacho. The network helps show where Iván Plaza-Menacho may publish in the future.

Co-authorship network of co-authors of Iván Plaza-Menacho

This figure shows the co-authorship network connecting the top 25 collaborators of Iván Plaza-Menacho. A scholar is included among the top collaborators of Iván Plaza-Menacho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván Plaza-Menacho. Iván Plaza-Menacho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sánchez, Jana, Wayland Yeung, Inés G. Muñoz, et al.. (2023). An allosteric switch between the activation loop and a c-terminal palindromic phospho-motif controls c-Src function. Nature Communications. 14(1). 6548–6548. 5 indexed citations
2.
Mohamed, Hossam Taha, et al.. (2022). Structural and dynamic determinants for highly selective RET kinase inhibition reveal cryptic druggability. Journal of Advanced Research. 45. 87–100. 5 indexed citations
3.
Dubey, Badri N., Raphael Böhm, Andreas Kaczmarczyk, et al.. (2019). Hybrid histidine kinase activation by cyclic di-GMP–mediated domain liberation. Proceedings of the National Academy of Sciences. 117(2). 1000–1008. 31 indexed citations
4.
Redaelli, Sara, Iván Plaza-Menacho, & Luca Mologni. (2018). Novel targeted therapeutics for MEN2. Endocrine Related Cancer. 25(2). T53–T68. 11 indexed citations
5.
Plaza-Menacho, Iván. (2017). Structure and function of RET in multiple endocrine neoplasia type 2. Endocrine Related Cancer. 25(2). T79–T90. 29 indexed citations
6.
Dubey, Badri N., Christian Lori, Shogo Ozaki, et al.. (2016). Cyclic di-GMP mediates a histidine kinase/phosphatase switch by noncovalent domain cross-linking. Science Advances. 2(9). e1600823–e1600823. 59 indexed citations
7.
Plaza-Menacho, Iván, Karin Barnouin, Rachael Barry, et al.. (2016). RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements. Cell Reports. 17(12). 3319–3332. 28 indexed citations
8.
Plaza-Menacho, Iván, Karin Barnouin, K.M. Goodman, et al.. (2014). Oncogenic RET Kinase Domain Mutations Perturb the Autophosphorylation Trajectory by Enhancing Substrate Presentation In trans. Molecular Cell. 53(5). 738–751. 57 indexed citations
9.
Plaza-Menacho, Iván, Luca Mologni, & Neil Q. McDonald. (2014). Mechanisms of RET signaling in cancer: Current and future implications for targeted therapy. Cellular Signalling. 26(8). 1743–1752. 66 indexed citations
10.
Morandi, Andrea, Lesley‐Ann Martin, Qiong Gao, et al.. (2013). GDNF–RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors. Cancer Research. 73(12). 3783–3795. 83 indexed citations
11.
Morandi, Andrea, Iván Plaza-Menacho, & Clare M. Isacke. (2011). RET in breast cancer: functional and therapeutic implications. Trends in Molecular Medicine. 17(3). 149–157. 72 indexed citations
12.
Plaza-Menacho, Iván, Andrea Morandi, Luca Mologni, et al.. (2011). Focal Adhesion Kinase (FAK) Binds RET Kinase via Its FERM Domain, Priming a Direct and Reciprocal RET-FAK Transactivation Mechanism. Journal of Biological Chemistry. 286(19). 17292–17302. 48 indexed citations
13.
Plaza-Menacho, Iván, Andrea Morandi, David Robertson, et al.. (2010). Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance. Oncogene. 29(33). 4648–4657. 111 indexed citations
14.
Esseghir, Selma, Shawn Todd, Toby Hunt, et al.. (2007). A Role for Glial Cell–Derived Neurotrophic Factor–Induced Expression by Inflammatory Cytokines and RET/GFRα1 Receptor Up-regulation in Breast Cancer. Cancer Research. 67(24). 11732–11741. 110 indexed citations
15.
Plaza-Menacho, Iván, Luca Mologni, Elisa Sala, et al.. (2007). Sorafenib Functions to Potently Suppress RET Tyrosine Kinase Activity by Direct Enzymatic Inhibition and Promoting RET Lysosomal Degradation Independent of Proteasomal Targeting. Journal of Biological Chemistry. 282(40). 29230–29240. 87 indexed citations
16.
17.
DeGroot, Jeroen, Iván Plaza-Menacho, Hein Schepers, et al.. (2006). Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations. Surgery. 139(6). 806–814. 51 indexed citations
18.
Plaza-Menacho, Iván, Grzegorz Burzynski, Jan Willem B. de Groot, Bart J. L. Eggen, & Robert M.W. Hofstra. (2006). Current concepts in RET-related genetics, signaling and therapeutics. Trends in Genetics. 22(11). 627–636. 84 indexed citations
19.
Burzynski, Grzegorz, Ilja M. Nolte, Jan Osinga, et al.. (2005). Identifying Candidate Hirschsprung Disease–Associated RET Variants. The American Journal of Human Genetics. 76(5). 850–858. 44 indexed citations
20.
Burzynski, Grzegorz, Ilja M. Nolte, Jan Osinga, et al.. (2004). Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2. European Journal of Human Genetics. 12(8). 604–612. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian C. Grabiner Breakdown of academic impact, for papers by Aleata A. Triplett Breakdown of academic impact, for papers by Anna L. Stratford Breakdown of academic impact, for papers by Heidi L. Kenerson Breakdown of academic impact, for papers by Paolo Salerno Breakdown of academic impact, for papers by Ayush Dagvadorj Breakdown of academic impact, for papers by Ploutarchos Anezinis Breakdown of academic impact, for papers by Bin Chang Breakdown of academic impact, for papers by Mika K. Derynck Breakdown of academic impact, for papers by Cuiqi Zhou
Rankless by CCL
2026